Tuberculosis Research Funding Trends 2005 — 2021

 For the first time in history, funding for tuberculosis (TB) research and development (R&D) hit a billion dollars worldwide in 2021. This marked a significant milestone that nonetheless falls significantly short of what’s needed to stay on track to end TB, according to a new report by Treatment Action Group (TAG) and the Stop TB Partnership.

The report Tuberculosis Research Funding Trends, 2005–2021 highlights that despite reaching US$1 billion in spending, funding for TB R&D is a mere fraction of what’s needed to achieve the United Nations sustainable development goal of ending TB as a pandemic by 2030. Every day, 4400 people continue to die from TB, a treatable and curable airborne infectious disease.


Read the full press release here

Previous Tuberculosis Research Funds

New Treatment Action Group and Stop TB Partnership Report: Funding for TB Research in 2019 Nears Half of Global Target
Tuberculosis Research Funding Trends, 2005–2019
Tuberculosis Research Funding Trends 2005 – 2018
Tuberculosis Research Funding Trends 2005 – 2017